For more information or confidential assistance
Call 800-306-3180

Four Cases Chosen as Taxotere Bellwethers

taxotere package
On March 9, four representative cases were chosen as the first to be tried in a series of bellwether trials regarding Sanofi-Aventis’s Taxotere (docetaxel). The drug manufacturer currently faces over 5,600 product liability cases alleging that the drug, prescribed for treatment of breast cancer, causes... Read More

Taxotere Plaintiffs Prevail in Request for MDL

Pursuant to an October 10 transfer order filed by the United States Judicial Panel on Multidistrict Litigation, cases involving claims against the maker of breast cancer drug Taxotere have been consolidated under the supervision of U.S. District Judge Lance Africk in the Eastern District of... Read More

Taxotere Hair Loss Lawsuit Filed by Louisiana Woman

A Louisiana woman filed suit on June 17,  alleging that her use of breast cancer drug Taxotere (docetaxel) resulted in permanent alopecia, or a total failure of her hair to regrow following treatment with the medication. According to the complaint, drug maker Sanofi-Aventis failed in... Read More

Taxotere Complaint Alleges Permanent Alopecia

Ami Dodson is suing Sanofi S.A. on grounds of strict products liability regarding the manufacturer’s chemotherapy drug Taxotere. According to her suit, neither Dodson nor her treating doctors were aware of or informed of the risks of permanent alopecia that can occur with treatment of... Read More